BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35771629)

  • 1. Persistent γ-H2AX Formation and Expression of Stem Cell Markers in N-Butyl-N-(4-Hydroxybutyl)Nitrosamine-Induced Bladder Carcinogenesis in Rats.
    Yamada T; Toyoda T; Matsushita K; Akane H; Morikawa T; Cho YM; Ogawa K
    Toxicol Sci; 2022 Aug; 189(1):51-61. PubMed ID: 35771629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose dependency of γ-H2AX formation in the rat urinary bladder treated with genotoxic and nongenotoxic bladder carcinogens.
    Yamada T; Toyoda T; Matsushita K; Morikawa T; Ogawa K
    J Appl Toxicol; 2020 Sep; 40(9):1219-1227. PubMed ID: 32203627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay.
    Wakui S; Mutou T; Takahashi H; Ikegami M; Wanibuchi H; Fukushima S
    J Appl Toxicol; 2015 Feb; 35(2):181-90. PubMed ID: 24888239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
    PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of stem cell markers as useful complementary factors in the early detection of urinary bladder carcinogens by immunohistochemistry for γ-H2AX.
    Yamada T; Toyoda T; Matsushita K; Cho YM; Akagi JI; Morikawa T; Mizuta Y; Ogawa K
    Arch Toxicol; 2021 Feb; 95(2):715-726. PubMed ID: 33211169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible mechanistic roles of anatomical and functional vascular changes in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Tatematsu M; Lurie AG; Rippey RM; Conran PB; Arai M; Fukushima S; Ito N
    Cancer Res; 1984 Jan; 44(1):278-84. PubMed ID: 6690039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats.
    Nakanowatari J; Fukushima S; Imaida K; Ito N; Nagase S
    Jpn J Cancer Res; 1988 Apr; 79(4):453-9. PubMed ID: 3133335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting effect of sodium chloride in 2-stage urinary bladder carcinogenesis in rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Shibata MA; Nakanishi K; Shibata M; Masui T; Miyata Y; Ito N
    Urol Res; 1986; 14(4):201-6. PubMed ID: 3787885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of γ-H2AX, a Biomarker for DNA Double-strand Breaks, in Urinary Bladders of N -Butyl- N -(4-Hydroxybutyl)-Nitrosamine-Treated Rats.
    Toyoda T; Akagi J; Cho YM; Mizuta Y; Onami S; Suzuki I; Ogawa K
    J Toxicol Pathol; 2013 Jun; 26(2):215-21. PubMed ID: 23914065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
    Chen T; Na Y; Wanibuchi H; Yamamoto S; Lee CC; Fukushima S
    Jpn J Cancer Res; 1999 Aug; 90(8):818-23. PubMed ID: 10543252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats.
    Fukushima S; Murasaki G; Hirose M; Nakanishi K; Hasegawa R; Ito N
    Acta Pathol Jpn; 1982 Mar; 32(2):243-50. PubMed ID: 7090816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of urinary potassium and sodium ion concentrations and pH on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats.
    Lina BA; Woutersen RA
    Carcinogenesis; 1989 Sep; 10(9):1733-6. PubMed ID: 2548752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of phenacetin and caffeine on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Nakanishi K; Fukushima S; Shibata M; Shirai T; Ogiso T; Ito N
    Gan; 1978 Jun; 69(3):395-400. PubMed ID: 669140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemically demonstrated variation in expression of cathepsin E between uracil-induced papillomatosis and N-butyl-N-(4-hydroxybutyl)nitrosamine-induced preneoplastic and neoplastic changes in rat urinary bladder.
    Yamamoto S; Yonezawa S; Ichinose M; Miki K; Masui T; Fukushima S; Inoue H; Tatematsu M
    Virchows Arch; 1996 Mar; 427(6):589-94. PubMed ID: 8605570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Murasaki G; Miyata Y; Babaya K; Arai M; Fukushima S; Ito N
    Gan; 1980 Jun; 71(3):333-40. PubMed ID: 7418979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Schistosoma haematobium and N-butyl-N-(4-hydroxybutyl)nitrosamine on the development of urothelial neoplasia in the baboon.
    Hicks RM; James C; Webbe G
    Br J Cancer; 1980 Nov; 42(5):730-55. PubMed ID: 7459210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vitamin A acetate on urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
    Miyata Y; Tsuda H; Matayoshi-Miyasato K; Fukushima S; Murasaki G; Ogiso T; Ito N
    Gan; 1978 Dec; 69(6):845-8. PubMed ID: 750276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyclophosphamide on rat urinary bladder epithelium treated wtih N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hirose M; Murasaki G; Imaida K; Fukushima S; Ito N
    Gan; 1980 Oct; 71(5):729-32. PubMed ID: 7227722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal suppression and induction of hyperplasia by the bladder carcinogens butyl(4-hydroxybutyl)nitrosamine and buty(3-carboxypropyl)nitrosamine in organ-cultured rat bladder epithelium.
    Reese DH; Friedman RD; Gaffield W; Keefer LK
    J Natl Cancer Inst; 1978 Jan; 60(1):219-23. PubMed ID: 628018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
    Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.